Epigastric Pain in Rheumatic Heart Disease
In patients with rheumatic heart disease (RHD) presenting with epigastric pain, you must immediately rule out cardiac ischemia before pursuing gastrointestinal causes, as these patients have significantly elevated cardiovascular risk and epigastric pain can be an atypical presentation of myocardial infarction.
Critical Initial Assessment
The evaluation must prioritize life-threatening cardiac causes given the established cardiovascular pathology in RHD patients:
Immediate Cardiac Evaluation Required
- ECG and cardiac biomarkers (troponin) are mandatory first-line tests 1
- Epigastric pain with shortness of breath, exertional symptoms, or radiation to the back demands urgent cardiac workup
- Patients with unexplained chest/epigastric pain have a 1.6-fold increased 10-year risk of hospitalization for ischemic heart disease and 2.4-fold increased mortality within the first year 2
- This cardiac risk is independent of endoscopic findings - normal upper endoscopy does not exclude cardiac disease 2
RHD-Specific Considerations
RHD patients face unique cardiovascular complications that can manifest as epigastric pain:
- Heart failure (most common presentation in endemic regions) 3, 4
- Atrial fibrillation with thromboembolic risk 4
- Infective endocarditis 4
- Pulmonary hypertension 5
Echocardiography should be performed to assess:
- Valve function and progression of disease 6, 7
- Chamber size and function
- Pulmonary artery pressures
- Signs of heart failure or new complications
Gastrointestinal Evaluation (After Cardiac Exclusion)
Once cardiac causes are excluded, pursue gastrointestinal etiologies systematically:
Clinical Features Suggesting GI Pathology
- Heartburn, regurgitation, dysphagia → GERD/esophagitis 1
- Nausea, vomiting, hematemesis → peptic ulcer disease (PUD), gastritis 1
- Pain radiating to back → pancreatitis (requires separate imaging protocol) 1
Diagnostic Approach
Upper endoscopy is the gold standard for diagnosing GERD, esophagitis, PUD, and gastritis 1
CT abdomen/pelvis may be appropriate when:
- Symptoms are nonspecific/overlapping 1
- Endoscopy is unavailable
- Concern for complications (perforation has 30% mortality) 1
CT findings suggestive of GI pathology:
- Distal esophageal wall thickening ≥5 mm (56% sensitivity, 88% specificity for reflux esophagitis) 1
- Air in mid/lower esophagus suggests GERD 1
Critical Pitfalls to Avoid
- Never assume epigastric pain is gastrointestinal in RHD patients without cardiac workup - this is the most dangerous error
- Anticoagulation status matters - many RHD patients are on warfarin for atrial fibrillation or prosthetic valves 4; GI bleeding risk is substantially elevated
- NSAIDs for pain relief are contraindicated - increase PUD risk and can worsen heart failure
- Benzathine penicillin prophylaxis must continue regardless of epigastric symptoms 3, 4
Management Algorithm
Step 1: ECG + troponin immediately
- If positive → cardiac pathway (ACS protocol)
- If negative → proceed to Step 2
Step 2: Assess for heart failure decompensation
- Echocardiography if not recently performed
- BNP/NT-proBNP
- If positive → optimize heart failure management
Step 3: Evaluate GI causes
- Upper endoscopy for typical GI symptoms
- CT abdomen/pelvis for nonspecific presentation or concern for complications
- Test for H. pylori if PUD suspected
Step 4: Treat identified pathology while maintaining:
- Secondary prophylaxis with benzathine penicillin 3, 4
- Anticoagulation if indicated (with PPI gastroprotection)
- Heart failure medications if applicable
The key distinction in RHD patients is the mandatory cardiac-first approach given their baseline cardiovascular vulnerability and the high stakes of missing cardiac pathology presenting as epigastric pain 2.